Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
American Journal of Clinical Oncology
|
August 1, 1995
Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer
P M LoRusso, P L Lomen, B G Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase Ib trial of bryostatin 1 in patients with refractory malignancies
S Grant, J Roberts, E Poplin, et al.
The Journal of Infusional Chemotherapy
|
January 1, 1996
A pilot trial of continuous infusion 5-fluorouracil with levamisole for adjuvant therapy of colon cancer
C G Leichman, E Poplin, M Zalupski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 1995
Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934)
P LoRusso, B J Foster, E Poplin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037)
E Poplin, T Fleming, L Leichman, et al.
Surgical Endoscopy
|
November 20, 2003
Plastic wound protectors do not affect wound infection rates following laparoscopic-assisted colectomy
K W Kercher, T H Nguyen, K L Harold, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1995
Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study
C Fabian, S Giri, N Estes, et al.
Investigational New Drugs
|
January 1, 1996
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks
B J Foster, P M LoRusso, E Poplin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma
M M Mita, E Poplin, C D Britten, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
American Journal of Clinical Oncology
|
August 1, 1995
Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer
P M LoRusso, P L Lomen, B G Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase Ib trial of bryostatin 1 in patients with refractory malignancies
S Grant, J Roberts, E Poplin, et al.
The Journal of Infusional Chemotherapy
|
January 1, 1996
A pilot trial of continuous infusion 5-fluorouracil with levamisole for adjuvant therapy of colon cancer
C G Leichman, E Poplin, M Zalupski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 1995
Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934)
P LoRusso, B J Foster, E Poplin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1987
Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037)
E Poplin, T Fleming, L Leichman, et al.
Surgical Endoscopy
|
November 20, 2003
Plastic wound protectors do not affect wound infection rates following laparoscopic-assisted colectomy
K W Kercher, T H Nguyen, K L Harold, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1995
Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study
C Fabian, S Giri, N Estes, et al.
Investigational New Drugs
|
January 1, 1996
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks
B J Foster, P M LoRusso, E Poplin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 6, 2012
Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma
M M Mita, E Poplin, C D Britten, et al.
Page
of 2